David Tollerud
Affiliations: | University of Louisville, Louisville, KY, United States |
Area:
Public Health, Occupational Health and SafetyGoogle:
"David Tollerud"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leventhal JR, Galvin J, Ison MG, et al. (2023) Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients. Transplantation |
| Leventhal JR, Elliott MJ, Yolcu ES, et al. (2015) Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation. 99: 288-98 |
| Leventhal J, Abecassis M, Miller J, et al. (2014) Chimerism and Tolerance Without GVHD in Mismatched Recipients of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker for Tolerance.: Abstract# C2094 Transplantation. 98: 900 |
| Leventhal J, Abecassis M, Miller J, et al. (2014) Five Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients.: Abstract# 2962 Transplantation. 98: 231 |
| Leventhal J, Abecassis M, Miller J, et al. (2013) Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation. 95: 169-76 |
| Leventhal J, Abecassis M, Miller J, et al. (2012) Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Science Translational Medicine. 4: 124ra28 |
| Ildstad S, Cheerva A, Tollerud D, et al. (2009) Stable Mixed Chimerism After Non-Myeloablative Transplant for Sickle Cell Disease: Normal Hematopoiesis Dominates Over Abnormal In Mixed Chimerism Biology of Blood and Marrow Transplantation. 15: 79 |
| Ildstad ST, Herzig R, Kaufman C, et al. (2000) SUMMARY OF A PHASE II PROTOCOL TO ATTEMPT TO INDUCE MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE TO RENAL AND CARDIAC ALLOGRAFTS.: Abstract# 703 Transplantation. 69 |
| Ildstad ST, Crilley P, Kaufman CL, et al. (2000) A GRAFT ENGINEERING METHOD TO ALLOW BONE MARROW TRANSPLANTATION (BMT) FOR MORE HIGHLY MISMATCHED RECIPIENTS WITH LEUKEMIA: MULTIVARIATE ANALYSIS OF A PHASE I/II PROTOCOL.: Abstract# 702 Transplantation. 69 |